MENUNews Archive
Date: 03/06/2024
Some oropharynx cancer patients may qualify for less radiation treatments, according to a new study from experts at the University of Michigan Health Rogel Cancer Center. This could assist many patients in a quicker return to their normal lives.
Date: 03/05/2024
Experts at University of Michigan Health Rogel Cancer Center have conducted the first study evaluating the effectiveness of a targeted drug for patients with salivary gland cancers (SGC).
Date: 02/28/2024
Researchers at the University of Michigan Health Rogel Cancer Center are exploiting a unique biological feature of glioblastoma to gain a better understanding of how this puzzling brain cancer develops and how to target new treatments against it. The team developed human and mouse models of glioblastoma oncostreams and examined multiple factors in the tumor microenvironment that could impact how oncostreams develop and how to reverse them.
Date: 02/06/2024
Programs and services aimed at helping people reduce their risk of cancer don’t always meet the needs of people from diverse communities and cultures.
Date: 01/23/2024
Equity in cancer care has long been an important theme for Lori Pierce, M.D. She made it a focus as president of the American Society of Clinical Oncology in 2021. So when the editors of The Cancer Journal selected health equity in cancer care as the topic for a recent special issue, Pierce, professor of radiation oncology at Michigan Medicine, was the ideal choice for guest editor.
Date: 01/15/2024
Lori J. Pierce, M.D., was one of 30 cancer scientists elected to the American Association for Cancer Research class of Fellows of the AACR Academy. Pierce was elected for illuminating contributions to establishing radiotherapy in the multimodality treatment of breast cancer, including intensity-modulated radiotherapy for node-positive breast cancer and incorporation of radiosensitizing agents, which have collectively resulted in improved treatment outcomes for breast cancer patients, most notably those harboring BRCA1/2 gene mutations.
Date: 01/12/2024
Researchers at the University of Michigan Health Rogel Cancer Center have identified a mechanism that causes severe gastrointestinal problems with immune-based cancer treatment. They also found a way to deliver immunotherapy’s cancer-killing impact without the unwelcome side effect.
Date: 01/09/2024
Research from Michigan Medicine experts is shedding light and potentially expanding options for patients living with medulloblastoma, an aggressive childhood cancer.
Date: 01/09/2024
Recently, Michigan Medicine became the first health care system in the Midwest to bring Recharge Rooms to its employees. These innovative, immersive mental health interventions were designed to support the well-being and resilience of the hospital’s health care workers.
Date: 12/31/2023
Within the last few years, nuclear medicine has added to cutting edge treatment options for cancer. One of the latest advancements is the use of a treatment called Pluvicto to treat metastatic castration-resistant prostate cancer.